Results 91 to 100 of about 239,349 (307)

Hematopoietic chimerism after allogeneic stem cell transplantation : a comparison of quantitative analysis by automated DNA sizing and fluorescent in situ hybridization

, 2005
Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is performed mainly in patients with high-risk or advanced hematologic malignancies and congenital or acquired aplastic anemias.
Wachowiak, Jacek, Tomasz Strabel, Peter Bader, Bader, Peter, Jólkowska, Justyna, Jacek Wachowiak, Michał Witt, Anna Pieczonka, Strabel, Tomasz, Pieczonka, Anna, Dariusz Boruczkowski, Boruczkowski, Dariusz, Justyna Jółkowska, Witt, Michal   +13 more
core   +1 more source

Combined Therapy with Shock Wave and Retrograde Bone Marrow-Derived Cell Transplantation for Osteochondral Lesions of the Talus [PDF]

, 2017
Fuqiang Gao, Na Chen, Wei Sun, Bailiang Wang, Zhencai Shi, Liming Cheng, Zirong Li, Wanshou Guo   +7 more
openalex   +1 more source

Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant

American Journal of Hematology, EarlyView.
ABSTRACT Graft versus host disease (GVHD) prophylaxis with posttransplant cyclophosphamide (ptCY) and cytomegalovirus (CMV) prophylaxis with letermovir have changed the clinical epidemiology of CMV infection. We studied the incidence, risk factors for, and outcomes of CMV infection after Day + 90 of allogeneic hematopoietic cell transplant (alloHCT ...
George L. Chen, Roland Bassett, Rohtesh S. Mehta, Betul Oran, Fareed Khawaja, Ella J. Ariza‐Heredia, Yosra Aljawai, Amanda Olson, May Daher, Portia Smallbone, Katayoun Rezvani, Partow Kebriaei, Uday Popat, Richard Champlin, Roy F. Chemaly, Elizabeth J. Shpall   +15 more
wiley   +1 more source

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients

, 2004
Forty-eight patients who provided 2 consecutive blood samples that tested positive for cytomegalovirus DNA by polymerase chain reaction (PCR) were randomized to receive either full-dose ganciclovir ( 5 mg/kg intravenously [iv] twice daily) or half-dose ...
Potter, M, Okwuadi, S., Amooty, G., Nebbia, G, Mattes, F. M., Griffiths, PD, Burroughs, A. K., Burroughs, AK, Grace, SC, Hainsworth, EG, Griffiths, P. D., Sweny, P, Grace, S. C., Amooty, G, Emery, V. C., Walker, AFH, Prentice, G., Sweny, P., Hainsworth, E. G., Geretti, AM, Nebbia, G., Sabin, C, Emery, VC, Sabin, C., Geretti, A. M., Potter, M., Brown, V. S., Okwuadi, S, Brown, VS, Hassan-Walker, A. F., Mattes, FM, Prentice, G   +31 more
core   +1 more source

Bone marrow chimerism and tolerance in organ transplantation.

, 1999
Hideki Taniguchi
openalex   +2 more sources

Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia [PDF]

, 1999
Andrew Grigg, Jeff Szer, J. Beresford, Anthony J. Dodds, Ken Bradstock, Simon Durrant, Anthony P. Schwarer, Timothy P. Hughes, Richard Herrmann, John Gibson, Chris Arthur, J.R.D. Matthews   +11 more
openalex   +1 more source

Allogeneic bone marrow transplantation in multiple myeloma

, 2018
Background and Methods: In contrast to autologous bone marrow transplants for hematologic cancers, allogeneic transplants contain no tumor cells that might cause a relapse.
Ljungman, Per, Cavo, Michele, Gore, Martin, Nikoskelainen, Jukka, Gahrton, Gösta, Brandt, Lena, Gratwohl, Alois, Reiffers, Josy J., Verdonck, Leo, European Group for Bone Marrow Transplantation, Belanger, Coralie, Facon, Thierry, Löwenberg, Bob, Samson, Diana, Volin, Liisa, Tura, Sante, Grañena Batista, Alberto   +16 more
core   +1 more source

Outcome of Autologous Bone Marrow Aspirate Concentrate (BMAC) Transplantation in Patient with Spinal Cord Injury: Our experiences

, 2017
Das S
openalex   +1 more source

Management of Iron Overload in Infants and Toddlers With Diamond–Blackfan Anemia Syndrome: A French–Italian Study

American Journal of Hematology, EarlyView.
ABSTRACT Diamond–Blackfan Anemia Syndrome (DBAS) is a rare congenital anemia often requiring chronic red blood cell transfusions from infancy. Without appropriate chelation, iron overload develops early and may be severe; however, no data are available on chelation in patients under 3 years of age.
Francesca Torchio, Baptiste Lecalvez, Emanuela Garelli, Coralie Mallebranche, Adriana Carando, Marie‐Pierre Castex, Nathalie Garnier, Marco Zecca, Nathalie Aladjidi, Elisa Bertoni, Arthur Sterin, Maria Licciardello, Anne Sirvent, Antonella Sau, Isabelle Marie, Benedicte Bruno, Lydie M. Da Costa, Franca Fagioli, Paola Quarello, Thierry Leblanc   +19 more
wiley   +1 more source

Therapeutic use of hematopoietic growth factors in bone marrow transplantation

The proliferation, differentiation, and function of hematopoietic cells is tightly regulated by a complex family of glycoprotein hormones, collectively described as hematopoietic growth factors [1–6].
Nimer, Stephen D, Champlin, Richard E
core   +1 more source